GenVivo Inc

GenVivo Inc. is a biotechnology company headquartered in San Marino, California. Currently, the company employs 34 individuals and generates approximately $50 million in annual revenue. GenVivo specializes in developing gene delivery technologies to combat cancer. Their innovative approach focuses on delivering drugs that activate the patient's immune system to target and destroy cancer cells. These therapies are designed to be readily available ("off-the-shelf"), eliminating the lengthy and expensive processes often associated with personalized cancer vaccines. GenVivo distinguishes itself through its commitment to providing accessible and efficient cancer treatment solutions. Their therapies aim to enhance the overall patient experience by offering a streamlined and effective approach to fighting cancer. For more information about GenVivo Inc. and their groundbreaking cancer treatments, visit their website at genvivoinc.com.